Heart Test Laboratories Inc. (NASDAQ:HSCS)’s traded shares stood at 1.08 million during the last session, with the company’s beta value hitting 3.40. At the close of trading, the stock’s price was $0.09, to imply an increase of 2.53% or $0.0 in intraday trading. The HSCS share’s 52-week high remains $1.32, putting it -1366.67% down since that peak but still an impressive 0.0% since price per share fell to its 52-week low of $0.09. The company has a valuation of $5.83M, with an average of 1.85 million shares over the past 3 months.

Heart Test Laboratories Inc. (NASDAQ:HSCS) trade information

After registering a 2.53% upside in the last session, Heart Test Laboratories Inc. (HSCS) has traded red over the past five days. The stock hit a weekly high of 0.0945, jumping 2.53% in its intraday price action. The 5-day price performance for the stock is -3.89%, and -21.03% over 30 days. With these gigs, the year-to-date price performance is -47.95%.

Heart Test Laboratories Inc. (HSCS) estimates and forecasts

The rating firms project that company’s revenue will grow 1,100.00% compared to the previous financial year.

Revenue forecast for the current quarter as set by 2 analysts is 50k. Meanwhile, for the current quarter, a total of 2 analyst(s) estimate revenue growth to 200k.

HSCS Dividends

Heart Test Laboratories Inc. has its next earnings report out in June. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Heart Test Laboratories Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.